Berry Anna E, Bearl David W
Internal Medicine-Pediatrics Residency Program, Monroe Carell Jr. Children's Hospital and Vanderbilt University Hospital, Vanderbilt University Medical Center, Nashville, TN, United States.
Division of Pediatric Cardiology, Department of Pediatrics, Monroe Carell Jr. Children's Hospital, Vanderbilt University Medical Center, Nashville, TN, United States.
Front Pediatr. 2023 Feb 24;11:1057903. doi: 10.3389/fped.2023.1057903. eCollection 2023.
Over the past 2 years advancements in the techniques and technology of pediatric heart transplantation have exponentially increased. However, even as the number of pediatric donor hearts has grown, demand for this limited resource continues to far outpace supply. Thus, lifesaving support in the form of ventricular assist devices (VAD) has become increasingly utilized in bridging pediatric patients to cardiac transplant. In the current pediatric heart transplant listing criteria, adopted by the United Network for Organ Sharing (UNOS) in 2016, all pediatric patients with a VAD are granted 1A status and assigned top transplant priority regardless of their underlying pathology. However, should this be the case? We suggest that the presence of a VAD alone may not be sufficient for status 1A listing. In doing so, we specifically highlight the heightened acuity, resource utilization, risk profile, and diminished outcomes in patients with single ventricle physiology supported with VAD as compared to patients with structurally normal hearts who would both be listed under 1A status. Given this, from a distributive justice perspective, we further suggest that the lack of granularity in current pediatric cardiac transplant listing categories may inadvertently lead to an inequitable distribution of donor organs and hospital resources especially as it pertains to those with single ventricle anatomy on VAD support. We propose revisiting the current listing priorities in light of improved techniques, technology, and recent data to mitigate this phenomenon. By doing this, pediatric patients with single ventricle disease might be more equitably stratified while awaiting heart transplant.
在过去的两年里,小儿心脏移植技术和工艺取得了指数级的进步。然而,即便小儿供体心脏数量有所增加,但对这一有限资源的需求仍远远超过供应。因此,作为挽救生命的支持手段,心室辅助装置(VAD)在将小儿患者过渡到心脏移植的过程中得到了越来越多的应用。在器官共享联合网络(UNOS)于2016年采用的现行小儿心脏移植登记标准中,所有使用VAD的小儿患者均被授予1A状态,并被赋予最高的移植优先级,而不论其潜在病理情况如何。然而,情况应该如此吗?我们认为,仅存在VAD可能不足以获得1A状态登记。在此过程中,我们特别强调了与结构正常心脏且同样被列为1A状态的患者相比,使用VAD支持的单心室生理患者的更高敏锐度、资源利用、风险状况及较差的预后。鉴于此从分配正义的角度来看,我们进一步认为,当前小儿心脏移植登记类别缺乏细致区分可能会无意中导致供体器官和医院资源的不公平分配,尤其是对于那些接受VAD支持且具有单心室解剖结构的患者而言。我们建议根据改进的技术、工艺和最新数据重新审视当前的登记优先级,以缓解这一现象。通过这样做,单心室疾病的小儿患者在等待心脏移植时可能会得到更公平的分层。